March 11, 2020 / 12:48 PM / 22 days ago

BRIEF-OncoSec Receives $850,000 From The Australian Research And Development Tax Incentive Program For TAVO Research And Development Work In 2019

March 11 (Reuters) - OncoSec Medical Inc:

* ONCOSEC RECEIVES $850,000 FROM THE AUSTRALIAN RESEARCH AND DEVELOPMENT (RESEARCH AND DEVELOPMENT) TAX INCENTIVE PROGRAM FOR TAVO™ RESEARCH AND DEVELOPMENT WORK IN 2019 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below